Works matching IS 11727047 AND DT 2025 AND VI 39 AND IP 1

Results: 9

Correction: Pharmacokinetic Characteristics of Long‑Acting Injectable Antipsychotics for Schizophrenia: An Overview: Correction: PK Characteristics of Long-Acting Injectable Antipsychotics: C. U. Correll et al.

Published in:

2025

By:

Correll, Christoph U.;
Kim, Edward;
Sliwa, Jennifer Kern;
Hamm, Wayne;
Gopal, Srihari;
Mathews, Maju;
Venkatasubramanian, Raja;
Saklad, Stephen R.

Publication type:

Correction Notice

Effects of One-Year Anti-seizure Treatment with Add-On Cenobamate on Bone Density and Bone Turnover in Adults with Drug-Resistant Focal Epilepsy: An Observational Study: Effects of Long-Term Cenobamate Treatment on Bone Density: Y. Novitskaya et al.

Published in:

CNS Drugs, 2025, v. 39, n. 1, p. 95, doi. 10.1007/s40263-024-01137-5

By:

Novitskaya, Yulia;
Schulze-Bonhage, Andreas;
Schütz, Elisa;
Hirsch, Martin

Publication type:

Article

Author's Reply to Zhou et al: Comment on "Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: A Retrospective Cohort Study in an Asian Population": Comment on Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: T. Miwa

Published in:

2025

By:

Miwa, Toru

Publication type:

Letter

Comment on "Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: A Retrospective Cohort Study in an Asian Population": Comment on "Effectiveness of Anti-Calcitonin Gene-Related Peptide...: X. Zhou et al.

Published in:

2025

By:

Zhou, Xin;
Zhang, Aiping;
Lin, Riyang

Publication type:

Letter

Measuring Disease Progression in Multiple Sclerosis Clinical Drug Trials and Impact on Future Patient Care: Measuring MS Disease Progression in Drug Trials and Its Impact on Future Patient Care: F. De Angelis et al.

Published in:

CNS Drugs, 2025, v. 39, n. 1, p. 55, doi. 10.1007/s40263-024-01132-w

By:

De Angelis, Floriana;
Nistri, Riccardo;
Wright, Sarah

Publication type:

Article

Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes: Safety of Antipsychotics and Mood Stabilizers in Pregnancy: E. Wang et al

Published in:

CNS Drugs, 2025, v. 39, n. 1, p. 1, doi. 10.1007/s40263-024-01131-x

By:

Wang, Enhui;
Liu, Yilin;
Wang, Yucheng;
Han, Xinyu;
Zhou, Yifang;
Zhang, Lingli;
Tang, Yanqing

Publication type:

Article

The Role of GABA Receptors in Anesthesia and Sedation: An Updated Review: The Role of GABA Receptors in Anesthesia and Sedation: A. B. Philip et al.

Published in:

CNS Drugs, 2025, v. 39, n. 1, p. 39, doi. 10.1007/s40263-024-01128-6

By:

Philip, Annlin Bejoy;
Brohan, Janette;
Goudra, Basavana

Publication type:

Article

TICA-CLOP STUDY: Ticagrelor Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke, a Randomized Controlled Multi-Center Trial: Ticagrelor Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke: S. R. Ahmed et al.

Published in:

CNS Drugs, 2025, v. 39, n. 1, p. 81, doi. 10.1007/s40263-024-01127-7

By:

Ahmed, Sherihan Rezk;
Nahas, Nevine El;
Khalil, Mohamed Fouad Elsayed;
Elbassiouny, Ahmed;
Almoataz, Mohamed Ahmed;
Omar, Tarek Youssif;
Daabis, Ahmed Mohamed Ali;
Refat, Hossam Mohamed;
Ebied, Ahmed Ahmed Mohamed Kamal;
Hassan, Asmaa Mohammed;
Mohamed, Diaa Mostafa Atiaa;
Ismaiel, Mohamed;
Zeinhom, Mohamed G.

Publication type:

Article

The Safety of Alcohol Pharmacotherapies in Pregnancy: A Scoping Review of Human and Animal Research: Alcohol Pharmacotherapy Safety in Pregnancy: E. Quintrell et al.

Published in:

CNS Drugs, 2025, v. 39, n. 1, p. 23, doi. 10.1007/s40263-024-01126-8

By:

Quintrell, Ebony;
Russell, Danielle J.;
Rahmannia, Sofa;
Wyrwoll, Caitlin S.;
Larcombe, Alexander;
Kelty, Erin

Publication type:

Article